People with MS who have heart surgery do not have higher in-hospital death or complication rates than others, but they are less likely to go straight home after the hospital stay.
Researchers looked at U.S. hospital records for people having major heart operations and compared those with and without MS. They found that while people with MS were younger and more often women, their chance of dying in the hospital after heart surgery was about the same as people without MS. The overall rate of complications like stroke, pneumonia, kidney problems, or blood clots was also similar between the two groups. People with MS were less likely to be sent directly home after their hospital stay, meaning more needed extra care or rehabilitation. Hospital length of stay and costs were about the same for people with and without MS.
People living with MS and their caregivers should know that heart surgery itself does not appear to raise the risk of dying in the hospital or having more medical complications compared to others. This is like learning the actual surgery risk is similar to other patients, even if MS adds other health issues. Caregivers and discharge planners should pay attention because people with MS are less likely to go straight home and may need plans for rehab, home help, or a short care facility. Surgeons and neurologists should work together before and after surgery to anticipate MS-related needs, which can help people return home sooner. Knowing this ahead of time helps families plan transportation, home support, or extra visits from nurses or therapists.
This study used hospital records, which can miss details like how severe a person’s MS is or their home support before surgery. The results show what happened in the hospital but do not tell us about long-term recovery after leaving the hospital. Because of these limits, talk with your care team about your personal risks and plans for going home or rehab.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/31/2026
Researchers found consistent gut bacteria differences in MS tied to disease type, treatment response
Read More7/1/2026
Study shows aerobic exercise alters brain circuits linked to automatic body control and fatigue in M
Read More7/1/2026
A simple eye scan and a blood test for sGFAP together help identify people with MS at higher risk of
Read More7/1/2026
MRI shows the choroid plexus is larger early in MS and links to inflammation and certain genes, sugg
Read More7/1/2026
A case shows rheumatoid arthritis can inflame the brain lining and cause focal seizures; prompt diag
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like JAMA surgery often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.